Abiopharma

🔍 Landman Yoav (Executive)

Company: JFrog Ltd (FROG)

Report Date: 2026-08-27

Detailed Transactions and Holdings:

• Sold 41,065 shares of Ordinary Shares at $99.4 per share (Direct)
  Date: 2026-08-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,407,273.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 108,348 shares of Ordinary Shares at $100.56 per share (Direct)
  Date: 2026-08-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,298,925.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 96,892 shares of Ordinary Shares at $101.43 per share (Direct)
  Date: 2026-08-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,202,033.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 2,995 shares of Ordinary Shares at $102.02 per share (Direct)
  Date: 2026-08-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,199,038.00 | transaction_form_type: 4 | Footnotes: F1, F5

Footnotes:

• F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 1, 2025.
• F2: This transaction was executed in multiple trades at prices ranging from $99.00 to $99.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F3: This transaction was executed in multiple trades at prices ranging from $100.00 to $100.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F4: This transaction was executed in multiple trades at prices ranging from $101.00 to $101.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F5: This transaction was executed in multiple trades at prices ranging from $102.00 to $102.05. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.